MAX
Summary: The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. It is able to form homodimers and heterodimers with other family members, which include Mad, Mxi1 and Myc. Myc is an oncoprotein implicated in cell proliferation, differentiation and apoptosis. The homodimers and heterodimers compete for a common DNA target site (the E box) and rearrangement among these dimer forms provides a complex system of transcriptional regulation. Mutations of this gene have been reported to be associated with hereditary pheochromocytoma. A pseudogene of this gene is located on the long arm of chromosome 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
MYC associated factor X | MIM:154950 | Ensembl:ENSG00000125952 | HGNC:HGNC:6913 | PA30656 | 14q23.3 |
GO terms in MAX
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | IDA | GO:0000790 | nuclear chromatin |
CC | IBA | GO:0005634 | nucleus |
CC | IDA | GO:0005634 | nucleus |
CC | TAS | GO:0005654 | nucleoplasm |
CC | IEA | GO:0005737 | cytoplasm |
CC | IEA | GO:0016605 | PML body |
CC | IEA | GO:0030425 | dendrite |
CC | IMP | GO:0032993 | protein-DNA complex |
CC | IDA | GO:0071339 | MLL1 complex |
CC | IBA | GO:0090575 | RNA polymerase II transcription factor complex |
CC | IDA | GO:0090575 | RNA polymerase II transcription factor complex |
BP | TAS | GO:0000082 | G1/S transition of mitotic cell cycle |
BP | IDA | GO:0000122 | negative regulation of transcription by RNA polymerase II |
BP | TAS | GO:0006366 | transcription by RNA polymerase II |
BP | IEA | GO:0009267 | cellular response to starvation |
BP | IEA | GO:0032868 | response to insulin |
BP | IBA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | IEA | GO:0048678 | response to axon injury |
BP | IEA | GO:0051402 | neuron apoptotic process |
BP | IEA | GO:0060041 | retina development in camera-type eye |
BP | IEA | GO:0065003 | protein-containing complex assembly |
BP | TAS | GO:0070317 | negative regulation of G0 to G1 transition |
BP | IEA | GO:0071375 | cellular response to peptide hormone stimulus |
BP | IEA | GO:1903508 | positive regulation of nucleic acid-templated transcription |
MF | IBA | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding |
MF | IDA | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding |
MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | ISM | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | NAS | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
MF | IBA | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding |
MF | IBA | GO:0001078 | transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | IDA | GO:0001078 | transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding |
MF | IDA | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding |
MF | IMP | GO:0003677 | DNA binding |
MF | TAS | GO:0003700 | DNA-binding transcription factor activity |
MF | TAS | GO:0003712 | transcription coregulator activity |
MF | TAS | GO:0003713 | transcription coactivator activity |
MF | IPI | GO:0005515 | protein binding |
MF | IMP | GO:0042803 | protein homodimerization activity |
MF | IEA | GO:0044877 | protein-containing complex binding |
MF | IEA | GO:0046982 | protein heterodimerization activity |
MF | IMP | GO:0070888 | E-box binding |
Gene expression in normal tissue: MAX
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in MAX
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP23 | B Cell Receptor Signaling Pathway |
wikipathways | WP3651 | Pathways Affected in Adenoid Cystic Carcinoma |
wikipathways | WP382 | MAPK Signaling Pathway |
wikipathways | WP400 | p38 MAPK Signaling Pathway |
pid | hdac_classi_pathway | Signaling events mediated by HDAC Class I |
pid | myc_activpathway | Validated targets of C-MYC transcriptional activation |
pid | myc_pathway | C-MYC pathway |
pid | myc_represspathway | Validated targets of C-MYC transcriptional repression |
pid | smad2_3nuclearpathway | Regulation of nuclear SMAD2/3 signaling |
pid | telomerasepathway | Regulation of Telomerase |
kegg | hsa04010 | MAPK signaling pathway - Homo sapiens (human) |
kegg | hsa05200 | Pathways in cancer - Homo sapiens (human) |
kegg | hsa05202 | Transcriptional misregulation in cancer - Homo sapiens (human) |
kegg | hsa05222 | Small cell lung cancer - Homo sapiens (human) |
biocarta | mapkpathway | mapkinase signaling pathway |
biocarta | p38mapkpathway | p38 mapk signaling pathway |
biocarta | tertpathway | overview of telomerase protein component gene htert transcriptional regulation |
reactome | R-HSA-1362277 | Transcription of E2F targets under negative control by DREAM complex |
reactome | R-HSA-1538133 | G0 and Early G1 |
reactome | R-HSA-1640170 | Cell Cycle |
reactome | R-HSA-212436 | Generic Transcription Pathway |
reactome | R-HSA-453279 | Mitotic G1-G1/S phases |
reactome | R-HSA-69202 | Cyclin E associated events during G1/S transition |
reactome | R-HSA-69206 | G1/S Transition |
reactome | R-HSA-69242 | S Phase |
reactome | R-HSA-69278 | Cell Cycle, Mitotic |
reactome | R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry |
reactome | R-HSA-73857 | RNA Polymerase II Transcription |
reactome | R-HSA-74160 | Gene expression (Transcription) |
reactome | R-HSA-8953750 | Transcriptional Regulation by E2F6 |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD870 | BRD63610 | 4 |
iGMDRD782 | DC-45-A2 | 2 |
iGMDRD434 | BMS-536924 | 2 |
iGMDRD84 | Lovastatin acid | 3 |
iGMDRD82 | Quiflapon | 3 |
iGMDRD886 | Compound 1541A | 2 |
iGMDRD61 | Kinetin riboside | 3 |
iGMDRD316 | N9-Isopropyl-olomoucine | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in MAX